Showing results 7 to 7 of 7
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology | 2006 |